Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
I'm Ready to Subscribe
Special Offers
DNBi. Leverage D&B's credit assessment tools.

Newron Pharmaceuticals · Bresso , Milano Italy (Swiss: NWRN)

Via Ludovico Ariosto 21Phone: +39-02-610-3461
Bresso MilanoFax: +39-02-610-34654
20091
ItalyMap Map This Company
  • Company Profiles
  • Competitive Landscapes
  • Industry Reports

Buy Reports

For a Hoover's Free Trial, Call
(866) 444-8642
or
Chat Now

Newron Pharmaceuticals Rankings

Company Description

Newron Pharmaceuticals focuses its brainpower on finding remedies for nervous system disorders. As a biopharmaceutical company focused on developing treatments for central nervous system diseases, Newron is developing a pipeline that includes treatments for Parkinson's disease and neuropathic back pain (pain which results from damage to nerve cells). The company is also in the early stages of developing treatments for Restless Leg Syndrome and Alzheimer's disease, as well as other neuropathic pain disorders. Newron partnered with Merck Serono for development of Newron's primary drug product Safinamide, a Parkinson's treatment. Biotie Therapies plans to acquire Newron for an estimated €45 million in late 2011.

To read the full description: Subscribe Now
left-headNewron Pharmaceuticals Reports
right-head

No subscription, no problem.

Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.

Shop Reports
Shop Reports

Financials

Company TypePublic - Swiss: NWRN Headquarters
Fiscal Year-EndDecember
Employees29

Executives

6 executives listed for Newron Pharmaceuticals's Bresso , Milano location.

CEO and Managing DirectorLuca BenattiE-mail
CFOStefan WeberE-mail
Chief Medical OfficerRavi AnandE-mail

More Newron Pharmaceuticals Executives

Top Newron Pharmaceuticals Competitors

Sponsored Links